As shown in Table 3, the presence of CISD2 protein was elevated in patients aged >=60 (P = 0.002), in those with the intestinal type of gastric cancer (P = 0.01), and in those with well‐differentiated cancers (P = 0.049). This evidence concerns the gene CISD2 and gastric cancer.